Nomura Holdings Inc. Makes New $1.05 Million Investment in Chemed Co. (NYSE:CHE)

Nomura Holdings Inc. acquired a new position in Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,988 shares of the company's stock, valued at approximately $1,053,000.

A number of other institutional investors have also made changes to their positions in the business. CIBC Asset Management Inc lifted its position in shares of Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock worth $242,000 after purchasing an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC raised its position in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after acquiring an additional 22 shares in the last quarter. CIBC Private Wealth Group LLC raised its position in Chemed by 13.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock worth $98,000 after acquiring an additional 22 shares in the last quarter. Independent Advisor Alliance raised its position in Chemed by 1.1% during the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock worth $1,207,000 after acquiring an additional 25 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in Chemed by 7.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock worth $264,000 after acquiring an additional 33 shares in the last quarter. Institutional investors own 95.85% of the company's stock.

Chemed Price Performance

NYSE CHE traded up $7.54 on Friday, hitting $568.98. 113,071 shares of the stock were exchanged, compared to its average volume of 103,064. The business's fifty day moving average is $583.60 and its 200 day moving average is $565.45. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The company has a market capitalization of $8.32 billion, a PE ratio of 28.75, a P/E/G ratio of 2.15 and a beta of 0.59.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. During the same period in the previous year, the company earned $5.20 earnings per share. The company's quarterly revenue was up 9.8% on a year-over-year basis. Analysts predict that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be issued a $0.50 dividend. The ex-dividend date is Thursday, May 29th. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. Chemed's dividend payout ratio is currently 9.74%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction dated Wednesday, May 7th. The shares were sold at an average price of $577.86, for a total transaction of $866,790.00. Following the completion of the transaction, the executive vice president now owns 16,127 shares in the company, valued at $9,319,148.22. This trade represents a 8.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,500 shares of company stock worth $4,401,120 over the last ninety days. Insiders own 3.29% of the company's stock.

Analyst Ratings Changes

Several research firms have issued reports on CHE. Wall Street Zen raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada upped their price target on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.